Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT-Reference-Cited by-同舟云学术

Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT

Published:2018-05-29 Issue:3 Volume:182 Page:418-422
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

McLornan Donal P.¹^ORCID,Szydlo Richard²,Robin Marie³,van Biezen Anja⁴,Koster Linda⁴,Blok Henrik J. P.⁴,Van Lint Maria T.⁵,Finke Jürgen⁶,Vitek Antonin⁷,Carlson Kristina⁸,Griskevicius Laimonas⁹,Holler Ernst¹⁰,Itälä-Remes Maija¹¹,Schaap Michel¹²,Socié Gerard³,Bay Jacques-Olivier¹³,Beguin Yves¹⁴,Bruno Benedetto¹⁵,Cornelissen Jan J.¹⁶,Gedde-Dahl Tobias¹⁷,Ljungman Per¹⁸,Rubio Marie T.¹⁹,Yakoub-Agha Ibrahim²⁰,Klyuchnikov Evgeny²¹,Olavarria Eduardo²,Chalandon Yves²²,Kröger Nicolaus²¹

Affiliation:

1. Comprehensive Cancer Centre; Division of Haematology, King's College; London

2. Hammersmith Hospital NHS Foundation Trust; London United Kingdom

3. Service d'Hématologie-Greffe; Hôpital Saint-Louis; Assistance Publique Hôpitaux de Paris; Paris France

4. EBMT Data Office; University Medical Centre; Leiden the Netherlands

5. Ospedale San Martino; Genova Italy

6. University of Freiburg; Freiburg Germany

7. Institute of Haematology and Blood Transfusion; Prague Czech Republic

8. University Hospital Uppsala; Uppsala Sweden

9. Haematology, Oncology& Transfusion Centre; Vilnius University Hospital Santaros Klinikos; Vilnius Lithuania

10. Department of Haematology and Oncology; University of Regensburg; Regensburg Germany

11. Stem Cell Transplant Unit; Turku University Hospital; Turku Finland

12. Department of Haematology; Radboud University Medical Centre; Nijmegen the Netherlands

13. Service d'hématologie clinique Adulte et pédiatrie; CHU ESTAING; Clermont France

14. Department of Haematology; University of Liege; Liege Belgium

15. A.O.U Citta della Salute e della Scienza di Torino; S.S.C.V.D Trapianto di Cellule Staminali; Torino Italy

16. Erasmus MC Cancer Institute; University Medical Centre; Rotterdam the Netherlands

17. Clinic for Cancer, Surgery and Transplantation; Oslo University Hospital; Rikshospitalet Norway

18. Department of Haematology; Karolinska University Hospital; Stockholm Sweden

19. Department of Haematology; Hopital d`Enfants; Nancy France

20. CHU de Lille; LIRIC; INSERM U995; Universite de Lille; Lille France

21. University Hospital Eppendorf; Hamburg Germany

22. Division of Haematology; Geneva University Hospitals; Geneva Switzerland

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.15407/fullpdf

Reference7 articles.

1. Ruxolitinib for myelofibrosis patients relapsing after allogeneic hematopoietic transplantation;Janson;Blood,2016

2. Donor lymphocyte infusions and second transplantation as salvage treatment for relapsed myelofibrosis after reduced-intensity allografting;Klyuchnikov;British Journal of Haematology,2012

3. Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation;Kröger;Blood,2009a

4. JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell transplantation;Kröger;Blood,2009b

5. Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group;Kröger;Leukemia,2015

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Graft-versus-host disease and impact on relapse in myelofibrosis undergoing hematopoietic stem cell transplantation;Bone Marrow Transplantation;2024-02-06

2. Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group;The Lancet Haematology;2024-01

3. Are transplant indications changing for myelofibrosis?;Hematology;2023-12-08

4. How I treat transplant-eligible patients with myelofibrosis;Blood;2023-11-16

5. Adoptive Immunotherapy via Donor Lymphocyte Infusions following Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: A Real-World, Retrospective Multicenter Study;Transplantation and Cellular Therapy;2023-11